ST
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Sao Tome and Principe
Clinical Trials Only
Reimbursed Care Access
São Tomé and Príncipe is a party to the major United Nations drug control conventions, which places an international obligation on the country to control psychotropic substances and many classic psychedelics. There is no public evidence of a regulated, reimbursed medical psychedelics program in the country; routine medical use is effectively limited to internationally established essential medicines (e.g., ketamine as an anesthetic) rather than psychedelic-assisted psychiatric treatments, and authorized use of other listed psychedelics is restricted to approved clinical research where it exists.
No clinical trials found for this country yet.